background
hepat
c
viru
hcv
induc
endoplasm
reticulum
er
stress
turn
activ
unfold
protein
respons
upr
upr
activ
three
distinct
signal
pathway
addit
upr
induc
autophagi
uprautophagi
pathway
hand
becom
clear
positivesinglestrand
rna
virus
util
autophagi
group
use
sirna
silenc
approach
show
autophagi
requir
hcv
rna
replic
howev
mechan
induct
uprautophagi
pathway
remain
unclear
cell
hcv
background
method
result
use
genomelength
hcv
rna
strain
genotyp
replic
system
hepatoma
cell
cell
control
use
cell
hcv
genom
remov
treatment
interferona
uprautophagi
pathway
activ
greater
degre
cell
compar
cell
rapamycin
mtorindepend
autophagi
induc
activ
hcv
replic
cell
hand
hcv
replic
cell
inhibit
inhibitor
autophagi
salubrin
eukaryot
initi
factor
alpha
phosphatas
inhibitor
xbox
bind
splice
inhibitor
cjun
ntermin
kinas
jnk
inhibitor
inhibit
hcv
replic
autophagi
addit
hcv
replic
autophagi
inhibit
strongli
combin
inhibitor
conclus
result
suggest
uprautophagi
pathway
exert
influenc
hcv
replic
therefor
control
pathway
may
serv
novel
therapeut
strategi
replic
hcv
hepat
c
viru
hcv
infect
major
caus
chronic
hepat
liver
cirrhosi
hepatocellular
carcinoma
million
peopl
chronic
infect
hcv
worldwid
diseas
emerg
seriou
global
health
problem
hcv
envelop
flaviviru
posit
singlestrand
rna
genom
develop
hcv
rna
replicon
capabl
replic
human
hepatoma
cell
line
signific
advanc
hcv
replic
occur
ribonucleoprotein
replic
complex
associ
endoplasm
reticulum
er
deriv
membran
web
group
shown
hcv
protein
disrupt
normal
er
function
induc
er
stress
mammalian
cell
trigger
respons
call
unfold
protein
respons
upr
cope
abnorm
er
function
er
stress
upr
activ
three
distinct
signal
pathway
name
activ
transcript
factor
pathway
inositolrequir
enzym
pathway
doublestrand
rnaactiv
protein
kinaselik
er
kinas
perk
pathway
group
report
exist
relationship
among
three
kind
uprautophagi
pathway
autophagi
major
intracellular
pathway
involv
degrad
recycl
longliv
protein
cytoplasm
organel
play
essenti
role
mainten
homeostasi
respons
starvat
cellular
stress
hand
autophagi
also
play
import
role
varieti
cellular
process
includ
restrict
intracellular
pathogen
multipl
recent
signific
autophagi
establish
viru
infect
becom
clear
particular
posit
singlestrand
rna
virus
util
autophagi
gener
cytoplasm
membran
structur
requir
genom
replic
hcv
also
shown
induc
er
stress
trigger
upr
furthermor
upr
activ
propos
respons
subsequ
induct
autophagi
howev
induct
uprautophagi
pathway
hcv
defin
elucid
yet
studi
attempt
examin
influenc
hcv
replic
uprautophagi
pathway
use
genomelength
hcv
rna
strain
genotyp
replic
system
luciferas
report
facilit
prompt
precis
monitor
hcv
rna
replic
hepatoma
cell
cell
tunicamycin
tm
rapamycin
interferon
ifn
alpha
purchas
sigma
st
loui
mo
usa
salubrin
purchas
calbiochem
lo
angel
ca
usa
anticor
purchas
institut
immunolog
institut
immunolog
tokyo
japan
antinonstructur
protein
ns
abcam
abcam
cambridg
uk
antimicrotubuleassoci
protein
light
chain
purchas
medic
biolog
laboratori
mbl
tokyo
japan
antiphospholylatedeukaryot
initi
factor
alpha
anticjun
ntermin
kinas
jnk
antiphospholylatedjnk
anticjun
antiphospholylatedcjun
antigapdh
cell
signal
cell
signal
inc
cell
describ
detail
ikeda
et
al
cell
line
clone
strain
genotyp
rna
replic
cell
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
calf
serum
penicillin
streptomycin
lgml
calbiochem
darmstadt
germani
passag
twice
week
split
ratio
control
cell
establish
elimin
genomelength
hcv
rna
cell
ifnalpha
treatment
iuml
week
sigmaaldrich
st
loui
mo
usa
without
describ
previous
total
rna
isol
use
rna
prep
mini
kit
qiagen
templat
cdna
synthesi
carri
lg
total
rna
use
high
capac
rnatocdna
kit
appli
biosystem
inc
onetenth
synthes
cdna
subject
pcr
follow
primer
pair
hcv
gapdh
western
blot
analysi
cell
harbor
cell
plate
sixwel
plate
cultur
h
treat
reagent
h
sampl
subject
nativ
gel
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
protein
transfer
polyvinyliden
difluorid
membran
millipor
react
appropri
antibodi
immun
complex
visual
super
signal
west
femto
substrat
pierc
detect
use
imag
analyz
system
fujifilm
cell
cultur
glass
slide
fix
paraformaldehyd
phosphatebuff
salin
pb
room
temperatur
min
two
wash
pb
cell
permeabil
room
temperatur
min
pb
contain
saponin
block
pb
contain
gelatin
gelatinpb
min
room
temperatur
cell
incub
gelatinpb
contain
appropri
antibodi
min
wash
three
time
pb
contain
tween
pbst
result
cell
incub
gelatinpb
contain
correspond
fluorescentconjug
secondari
antibodi
min
wash
three
time
pbst
stain
cell
cover
vectashield
mount
medium
contain
dapi
vector
laboratori
inc
observ
fluoview
laser
scan
confoc
microscop
olympu
monitor
effect
reagent
rl
assay
perform
describ
previous
briefli
cell
plate
onto
plate
cell
per
well
triplic
cultur
medium
absenc
h
cell
treat
reagent
variou
concentr
h
treatment
cell
subject
luciferas
assay
use
rl
assay
system
promega
madison
wi
assay
effect
concentr
reagent
hcv
replic
determin
cell
plate
onto
plate
cell
per
well
triplic
treat
variou
concentr
reagent
h
treatment
cell
subject
cell
prolifer
assay
takara
bio
otsu
japan
accord
manufactur
protocol
base
assay
result
cytotox
concentr
reagent
estim
select
index
si
valu
reagent
also
estim
divid
valu
valu
luciferas
activ
statist
compar
variou
treatment
group
use
student
ttest
p
valu
consid
signifi
statist
signific
differ
mean
standard
deviat
determin
least
three
independ
experi
determin
whether
autophagi
induc
cell
investig
phosphoethanolamin
pe
conjug
cell
show
autonom
replic
hcv
rna
amount
significantli
increas
cell
compar
cell
fig
autophagi
involv
respons
er
stress
repres
upr
case
doublemembran
vesicl
form
fuse
lysosom
accumul
report
caus
lysosom
fusion
inhibit
also
experi
signific
accumul
observ
cell
fig
fig
show
increas
amount
phosphoryl
cell
compar
cell
suggest
perk
pathway
activ
hcv
fig
indic
increas
amount
splice
cell
compar
cell
suggest
pathway
activ
fig
show
increas
amount
cell
compar
cell
moreov
increas
amount
phosphoryl
jnk
phosphoryl
cjun
also
observ
cell
compar
cell
fig
suggest
pathway
activ
well
hand
treatment
cell
tunicamycin
trigger
upr
inhibit
glycosyl
result
activ
perk
pathway
result
confirm
delay
appear
upr
due
inher
defect
cell
fig
tunicamycin
treatment
also
induc
accumul
fig
data
confirm
hcv
replicon
cell
show
activ
autophagi
upr
fig
investig
whether
activ
autophagi
influenc
hcv
replic
rapamycin
mtorindepend
autophagi
induc
enhanc
hcv
replic
format
autophagosom
cell
wherea
inhibitor
autophagi
suppress
hcv
replic
format
autophagosom
cell
fig
b
data
suggest
autophagi
seem
somehow
facilit
hcv
replic
salubrin
select
inhibitor
phosphatas
complex
dephosphoryl
perk
pathway
select
inhibit
splice
downregul
express
dephosphoryl
jnk
investig
whether
inhibit
uprautophagi
pathway
might
affect
rate
hcv
replic
determin
si
valu
salubrin
inhibitor
xbox
bind
inhibitor
jnk
inhibitor
use
assay
system
result
si
valu
follow
salubrin
lm
lm
si
fig
lm
lm
si
fig
lm
lm
si
fig
meanwhil
percentag
viabl
cell
determin
assay
cytotox
effect
observ
lm
salubrin
fig
lm
fig
lm
fig
hand
cytotox
effect
observ
presenc
lm
salubrin
fig
lm
fig
lm
fig
addit
autophagosom
format
cell
decreas
presenc
concentr
salubrin
fig
found
inhibitor
result
effici
suppress
hcv
replic
autophagi
attempt
clarifi
three
uprautophagi
pathway
might
close
involv
activ
autophagi
investig
effect
combin
use
salubrin
rate
hcv
replic
use
assay
system
salubrin
inhibit
phasphoryl
hcv
core
protein
inhibit
splice
phasphoryl
jnk
inhibit
phasphoryl
jnk
splice
hcv
core
protein
inhibit
phasphoryl
combin
treatment
three
inhibitor
salubrin
strongli
enhanc
inhibit
hcv
replic
autophagi
result
indic
combin
use
inhibitor
effect
use
inhibitor
alon
suppress
hcv
replic
autophagi
fig
addit
concentr
inhibitor
use
combin
affect
cell
viabil
rate
fig
thu
regard
efficaci
inhibit
hcv
replic
autophagi
combin
use
appear
effici
compar
use
combin
studi
show
use
replicon
system
activ
hcv
three
main
signal
pathway
upr
autophagi
fig
regard
pathway
tardif
kd
et
al
report
studi
use
subgenom
replicon
hcv
suppress
pathway
stimul
synthesi
viral
protein
differ
result
could
attribut
fact
use
fullgenom
replicon
differ
hcv
strain
experi
addit
group
shown
hcv
induc
er
stress
upr
activ
hand
sever
group
report
autophagi
andor
autophagi
gene
like
play
antivir
provir
role
life
cycl
pathogenesi
mani
differ
viru
famili
especi
replic
spread
positivestrand
rna
virus
regul
interact
host
autophagi
machineri
compon
autophag
machineri
seem
subvert
promot
replic
rna
virus
case
infect
coronaviru
mous
hepat
viru
mhv
polioviru
rhinovirus
gener
membran
scaffold
rna
replic
attempt
determin
inhibitor
upr
signal
might
control
hcv
replic
autophagi
inhibit
signal
pathway
urp
autophagi
fig
result
show
salubrin
phosphatas
inhibitor
inhibitor
jnk
inhibitor
could
regul
hcv
replic
autophagi
cell
fig
next
attempt
determin
combin
inhibitior
uprautophagi
pathway
might
greatest
influenc
regul
hcv
replic
concentr
inhibitor
use
cell
viabil
hcv
replicon
almost
particular
combin
treatment
splice
inhibitor
jnk
inhibitor
effici
reduc
hcv
replic
fig
interest
find
report
previous
phosphatas
inhibit
assembl
ribosom
inhibit
protein
synthesi
hand
promot
transcript
upr
target
gene
process
mrna
gener
matur
mrna
splice
bind
directli
er
stress
respons
element
unfold
protein
respons
element
activ
transcript
molecular
chaperon
er
jnk
activ
mediat
requir
autophagosom
format
perk
pathway
independ
upr
howev
pathway
play
complementari
role
upr
signal
find
indic
inhibit
uprautophagi
pathway
may
signific
influenc
suppress
hcv
replic
might
inhibit
strongli
hcv
replic
autophagi
conclus
hcv
stimul
three
signal
pathway
upr
autophagi
salubrin
phosphatas
inhibitor
inhibitor
jnk
inhibitor
act
potent
antiautophagi
agent
limit
inhibit
autophagi
hcv
replic
lead
notion
hcv
may
hijack
uprautophagi
pathway
hcv
replic
fig
studi
demonstr
control
uprautophagi
pathway
machineri
possibl
antivir
drug
target
combin
treatment
inhibitor
upr
signal
enhanc
inhibit
hcv
replic
effect
combin
treatment
salubrin
phosphatas
inhibitor
splice
inhibitor
jnk
inhibitor
hcv
replic
assay
system
examin
cell
treat
reagent
h
follow
rl
assay
bar
graph
assay
line
graph
perform
rel
valu
calcul
point
level
nontreat
cell
set
present
western
blot
analysi
treat
cell
hcv
core
protein
also
perform
lower
panel
